PEPTIDE CORTEXThe library
← The library

Desmopressin (DDAVP)

GI/Bone/Other
Evidence grade
AFDA-approved Rx (labeled use)
Cardiovascular · 0–5 · separate axis
1
PurposeEndocrine / Hemostasis
MechanismVasopressin analog; reduces urine output; increases vWF release
EffectsVasopressin analog; reduces urine output; increases vWF release
DosingNo human dose established.
Bottom lineStrongest data when used for its labeled indication under clinician guidance.
Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Hyponatremia/seizure risk; requires monitoring

Hyponatremia risk—caution with SSRIs/SNRIs, diuretics; fluid restriction and sodium monitoring.

CV 1 of 5 — Limited direct cardiovascular evidence.